Results 111 to 120 of about 7,191 (206)

A multicenter study on rates and risk factors of proliferative vitreoretinopathy in a low-income economy. [PDF]

PLoS One
Okonkwo ON, Udoh MM, Adenuga O, Ovienria W, Ibanga A, Nkanga D, Oyekunle I, Akanbi T, Agweye C.   +8 more
europepmc   +1 more source

Transition to Chronic Fibrosis in an Animal Model of Retinal Detachment With Features of Proliferative Vitreoretinopathy. [PDF]

Invest Ophthalmol Vis Sci, 2023
Peterson C, Lu Y, Santiago CP, Price AC, McNally MM, Schubert W, Nassar K, Zollner T, Blackshaw S, Eberhart CG, Singh MS.   +10 more
europepmc   +1 more source

Macular internal limiting membrane peel for eyes undergoing vitrectomy for retinal detachment: Rationalizing selection based on the severity of proliferative vitreoretinopathy

, 2021
Gaurav Mohan Kohli, Pratik Shenoy, Sachin Shetty, Ayush Mahendra Sangole, Alok Sen   +4 more
openalex   +1 more source

Risk factors for proliferative vitreoretinopathy after retinal detachment surgery: A systematic review and meta-analysis. [PDF]

PLoS One, 2023
Xiang J, Fan J, Wang J.
europepmc   +1 more source

The T309G MDM2 Gene Polymorphism Is a Novel Risk Factor for Proliferative Vitreoretinopathy

, 2013
Salvador Pastor‐Idoate, Irene Rodríguez‐Hernández, Jimena Rojas, Itziar Fernández, María T. García-Gutiérrez, José M. Ruiz‐Moreno, Amândio Rocha‐Sousa, Yashin Ramkissoon, Steven Harsum, Robert E. MacLaren, David G. Charteris, Jan C. vanMeurs, Rogelio González‐Sarmiento, José Carlos Pastor Jimeno   +13 more
openalex   +2 more sources

TNF-α and NF-κB signaling play a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy

, 2022
Victor Wang, Alison Heffer, Elisa Roztocil, Steven E. Feldon, Richard T. Libby, Collynn F. Woeller, Ajay E. Kuriyan   +6 more
openalex   +2 more sources

Development and validation of the Artificial Intelligence-Proliferative Vitreoretinopathy (AI-PVR) Insight system for deep learning-based diagnosis and postoperative risk prediction in proliferative vitreoretinopathy using multimodal fundus imaging. [PDF]

Quant Imaging Med Surg
Gan F, Cao J, Fan H, Qin W, Li X, Wan Q, Liu T, Liu K, You Z.   +8 more
europepmc   +1 more source

What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?

, 2022
Peter Wiedemann
openalex   +2 more sources

An analysis of heavy silicone oil treatment for inferior proliferative vitreoretinopathy. [PDF]

BMC Ophthalmol
Hammer M, Ie A, Eibenberger K, Auffarth GU, Xue K.   +4 more
europepmc   +1 more source

Inhibition of proliferative vitreoretinopathy by a newly developed methotrexate loaded drug carrier in vitro

, 2022
Sebastian S. Arrow, Simone C. Felis, Anna Hillenmayer, Laura D. Strehle, Susanna Koenig, Efstathios Vounotrypidis, Armin Wolf, Christian Wertheimer   +7 more
openalex   +1 more source